Germany Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	103
ISBN Number	not applicable
Product Code	GMD07260

Price

£2,055.00
approximately: $3,003 | €2,252

PDF

Order above formats by FAX

Summary

Germany Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012

This report is an essential source for in-depth information and data relating to the Germany diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices in Germany

Scope

The report provides diabetes care devices information broken down into detailed categories and segments in Germany.
Total revenues, products sold, end users, and average pricing.
Market shares of all the key competitors.
Key pipeline products that are set to shape the market, broken down by sector.
Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and IPOs.

Customer, hospitals and physicians data.

Reasons to buy

Gain a strong understanding of the diabetes care devices market in Germany.
Evaluate and compare the attractiveness of the market in the country.
Identify growth segments and opportunities in each industry sector within the country.
Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
Analyze the competitiveness of the market in the country and identify hotspots.
Develop strategies based on the latest product, brand, expansion and research and development news in the country.
Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content

1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
- 3.1 Diabetes Care Devices
- 3.2 Glucose Monitoring
  - 3.2.1 Blood Glucose Meter
  - 3.2.2 Blood Glucose Strips
- 3.3 Insulin Delivery
  - 3.3.1 Insulin Jet Injector
  - 3.3.2 Insulin Pen
  - 3.3.3 Insulin Pump
  - 3.3.4 Insulin Syringes
4 Healthcare Sector Review
- 4.1 Healthcare Sector
- 4.2 Healthcare Expenditure
- 4.3 Healthcare Infrastructure
  - 4.3.1 Healthcare Personnel Data
  - 4.3.2 Healthcare Facilities Data
- 4.4 Healthcare Policy
5 Regulation System
- 5.1 Medical Equipment Approval Process
  - 5.1.1 Classification of Medical Devices
- 5.2 Conformity Assessment Process
  - 5.2.1 Class I devices
  - 5.2.2 Class IIa devices
  - 5.2.3 Class IIb devices
  - 5.2.4 Class III devices
- 5.3 Post Market Surveillance
6 Pricing and Reimbursement
- 6.1 SHI
  - 6.1.1 Private Health Insurance
  - 6.1.2 Diagnosis Related Groups (DRG)
7 Distribution Structure
8 Germany Medical Equipment Cross Market Comparison
9 Diabetes Care Devices Cross Country Comparison
10 Diabetes Care Devices in Germany
- 10.1 Diabetes Care Devices Overall Revenues by Category (2000-2012)
- 10.2 Diabetes Care Devices Overall Volume by Category (2000-2012)
- 10.3 Diabetes Care Devices Overall Company Share (2006-2007)
11 Glucose Monitoring in Germany
- 11.1 Glucose Monitoring Revenues by Segment (2000-2012)
- 11.2 Glucose Monitoring Volume by Segment (2000-2012)
- 11.3 Glucose Monitoring Average Price (2000-2012)
- 11.4 Glucose Monitoring Distribution Share (2006-2007)
- 11.5 Glucose Monitoring Company Share (2006-2007)
12 Insulin Delivery in Germany
- 12.1 Insulin Delivery Revenue by Segment (2000-2012)
- 12.2 Insulin Delivery Volume by Segment (2000-2012)
- 12.3 Insulin Delivery Average Price (2000-2012)
- 12.4 Insulin Delivery Distribution Share (2006-2007)
- 12.5 Insulin Delivery Company Share (2006-2007)
13 F. Hoffmann-La Roche Ltd. Company Profile
- 13.1 Company Overview
- 13.2 Major Products and Services
  - 13.2.1 Products:
- 13.3 Value Chain Analysis
  - 13.3.1 Manufacturing
    - 13.3.1.1 In House Manufacturing
    - 13.3.1.2 Outsourcing
  - 13.3.2 Product Development
    - 13.3.2.1 Regulatory Approvals
    - 13.3.2.2 Clinical Trials
    - 13.3.2.3 Research and Development
  - 13.3.3 Sales and Marketing
    - 13.3.3.1 Partnerships and Alliances
- 13.4 F. Hoffmann-La Roche Ltd. Pipeline Products
  - 13.4.1 Automated Pancreas
    - 13.4.1.1 Products Overview
    - 13.4.1.2 Product Description
    - 13.4.1.3 Product Status
  - 13.4.2 Accu-Chek Aviva Nano
    - 13.4.2.1 Products Overview
    - 13.4.2.2 Product Description
    - 13.4.2.3 Product Status
14 LifeScan, Inc. Company Profile
- 14.1 Company Overview
- 14.2 Major Products and Services
  - 14.2.1 Products:
- 14.3 LifeScan, Inc. Pipeline Products
  - 14.3.1 Blood Glucose Test
    - 14.3.1.1 Product Overview
    - 14.3.1.2 Product Description
    - 14.3.1.3 Product Status
  - 14.3.2 OneTouch glucose meter
    - 14.3.2.1 Product Overview
    - 14.3.2.2 Product Description
    - 14.3.2.3 Product Status
    - 14.3.2.4 Product Milestone
    - 14.3.2.5 Product Patent Details
15 Abbott Laboratories Company Profile
- 15.1 Company Overview
- 15.2 Major Products and Services
  - 15.2.1 Products:
- 15.3 Value Chain Analysis
  - 15.3.1 Manufacturing
    - 15.3.1.1 In House Manufacturing
  - 15.3.2 Product Development
    - 15.3.2.1 Regulatory Approvals
    - 15.3.2.2 Clinical Trials
    - 15.3.2.3 Research and Development
  - 15.3.3 Sales and Marketing
    - 15.3.3.1 Partnerships and Alliances
- 15.4 Abbott Laboratories Pipeline Products
  - 15.4.1 FreeStyle Navigator Continuous Glucose Monitoring System
    - 15.4.1.1 Product Overview
    - 15.4.1.2 Product Description
    - 15.4.1.3 Product Status
    - 15.4.1.4 Clinical Trials
    - 15.4.1.5 Product Milestone
16 Novo Nordisk A/S Company Profile
- 16.1 Company Overview
- 16.2 Major Products and Services
  - 16.2.1 Products:
- 16.3 Novo Nordisk A/S Pipeline Products
  - 16.3.1 Future insulin infusion systems
    - 16.3.1.1 Product Overview
    - 16.3.1.2 Product Description
    - 16.3.1.3 Product Status
  - 16.3.2 Next generation durable pen
    - 16.3.2.1 Product Overview
    - 16.3.2.2 Product Description
    - 16.3.2.3 Product Status
  - 16.3.3 Next generation needles
    - 16.3.3.1 Product Overview
    - 16.3.3.2 Product Description
    - 16.3.3.3 Product Status
17 Becton, Dickinson and Company Profile
- 17.1 Company Overview
- 17.2 Major Products and Services
  - 17.2.1 Products:
- 17.3 Value Chain Analysis
  - 17.3.1 Manufacturing
    - 17.3.1.1 In House Manufacturing
  - 17.3.2 Product Development
    - 17.3.2.1 Regulatory Approvals
    - 17.3.2.2 Research and Development
  - 17.3.3 Sales and Marketing
    - 17.3.3.1 Partnerships and Alliances
18 B. Braun Melsungen AG Company Profile
- 18.1 Company Overview
- 18.2 Major Products and Services
  - 18.2.1 Products:
- 18.3 Value Chain Analysis
  - 18.3.1 Manufacturing
    - 18.3.1.1 In House Manufacturing
    - 18.3.1.2 Outsourcing
  - 18.3.2 Product Development
    - 18.3.2.1 Regulatory Approvals
    - 18.3.2.2 Clinical Trials
    - 18.3.2.3 Research and Development
  - 18.3.3 Sales and Marketing
    - 18.3.3.1 Partnerships and Alliances
    - 18.3.3.2 Licensing Agreements
19 Bayer HealthCare AG Company Profile
- 19.1 Company Overview
- 19.2 Major Products and Services
  - 19.2.1 Products:
- 19.3 Value Chain Analysis
  - 19.3.1 Manufacturing
    - 19.3.1.1 In House Manufacturing
    - 19.3.1.2 Outsourcing
  - 19.3.2 Product Development
    - 19.3.2.1 Regulatory Approvals
    - 19.3.2.2 Clinical Trials
    - 19.3.2.3 Research and Development
  - 19.3.3 Sales and Marketing
    - 19.3.3.1 Partnerships and Alliances
    - 19.3.3.2 Licensing Agreements
20 Sanofi-Aventis
- 20.1 Company Overview
- 20.2 Major Products and Services
  - 20.2.1 Products:
21 EKF-diagnostic GmbH Company Review
- 21.1 Company Overview
- 21.2 Major Products and Services
22 Appendix
- 22.1 Global Markets Direct Research Methodology
- 22.2 Coverage
- 22.3 Secondary Research
- 22.4 Primary Research
- 22.5 Models
- 22.6 Forecasts
- 22.7 Expert Panels
- 22.8 Currency Conversion
- 22.9 Contact Us
- 22.10 Disclaimer
1 List of Tables
- Table 1: Healthcare Personnel by Region in Germany, 2006
- Table 2: Doctors by Specialty in Germany, 2005-2007
- Table 3: Hospitals by Region in Germany, 2006
- Table 4: Hospital Beds by Region in Germany, 2006
- Table 5: Rehabilitation Centers by Region in Germany, 2004
- Table 6: Rehabilitation Center Beds by Region in Germany, 2004
- Table 7: Discharges by Diagnosis in Germany, 2004
- Table 8: Germany, Medical Equipment Market Comparison
- Table 9: Diabetes Care Devices Market, Country Comparison
- Table 10: Diabetes Care Devices, Germany, Category Revenues ($ mn), 2000-2012
- Table 11: Diabetes Care Devices Market, Germany, Portfolio Analysis
- Table 12: Diabetes Care Devices, Germany, Category Revenues ($ mn), Historic, 2000-2007
- Table 13: Diabetes Care Devices, Germany, Category Revenues ($ mn), Forecast, 2007-2012
- Table 14: Diabetes Care Devices, Germany, Category Volume (Units), 2000-2012
- Table 15: Diabetes Care Devices, Germany, Category Volume (Units), Historic, 2000-2007
- Table 16: Diabetes Care Devices, Germany, Category Volume (Units), Forecast, 2007-2012
- Table 17: Diabetes Care Devices, Germany, Overall Company Share by Revenue ($ mn), 2006-2007
- Table 18: Glucose Monitoring, Germany, Revenue ($ mn) by Segment, Historic, 2000-2007
- Table 19: Glucose Monitoring, Germany, Revenue ($ mn) by Segment, Forecast, 2007-2012
- Table 20: Glucose Monitoring, Germany, Volume (Units) by Segment, Historic, 2000-2007
- Table 21: Glucose Monitoring, Germany, Volume (Units) by Segment, Forecast, 2007-2012
- Table 22: Glucose Monitoring, Germany, Average Price ($), Historic, 2000-2007
- Table 23: Glucose Monitoring, Germany, Average Price ($), Forecast, 2007-2012
- Table 24: Glucose Monitoring, Germany, Distribution Share by Revenue ($ mn), 2006-2007
- Table 25: Glucose Monitoring, Germany, Company Share by Revenue ($ mn), 2006-2007
- Table 26: Insulin Delivery , Germany, Revenue ($ mn) by Segment, Historic, 2000-2007
- Table 27: Insulin Delivery , Germany, Revenue ($ mn) by Segment, Forecast, 2007-2012
- Table 28: Insulin Delivery , Germany, Volume (Units) by Segment, Historic, 2000-2007
- Table 29: Insulin Delivery , Germany, Volume (Units) by Segment, Forecast, 2007-2012
- Table 30: Insulin Delivery, Germany, Average Price ($), Historic, 2000-2007
- Table 31: Insulin Delivery, Germany, Average Price ($), Forecast, 2007-2012
- Table 32: Insulin Delivery , Germany, Distribution Share by Revenue ($ mn), 2006-2007
- Table 33: Insulin Delivery , Germany, Company Share by Revenue ($ mn), 2006-2007
- Table 34: Currency Conversion from USD to Local Currency at 2007 Constant Rate
- 1.2 List of Figures
- Figure 1: Total Healthcare Expenditure in Germany, 2000 - 2006
- Figure 2: Healthcare Structure in Germany, 2000 - 2006
- Figure 3: Healthcare Expenditure Sources in Germany, 2003
- Figure 4: Healthcare Expenditure by Disease Type, (%), 2004
- Figure 5: Healthcare Financing Framework in Germany, 2007
- Figure 6: Flowchart for Classification of Non-invasive Devices in Germany, 2007
- Figure 7: Flowchart for Classification of Invasive Devices in Germany, 2007
- Figure 8: Flowchart for Classification of Invasive Devices in Germany, 2007
- Figure 9: Classification of Invasive Devices in Germany, 2007
- Figure 10: Classification of Invasive Devices in Germany, 2007
- Figure 11: Flowchart for Classification of Active Devices in Germany, 2007
- Figure 12: Flowchart for Classification of Active Devices in Germany, 2007
- Figure 13: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Germany, 2007
- Figure 14: Conformity Assessment of Class-I Medical Devices in Germany, 2007
- Figure 15: Conformity Assessment of Class-IIa Medical Devices in Germany, 2007
- Figure 16: Conformity Assessment of Class-IIb Medical Devices in Germany, 2007
- Figure 17: Conformity Assessment of Class-III Medical Devices in Germany, 2007
- Figure 18: Germany, Medical Equipment Market Comparison,2007
- Figure 19: Diabetes Care Devices, Revenues ($ mn) by Country, 2000-2012
- Figure 20: Diabetes Care Devices Market, Country Comparison
- Figure 21: Diabetes Care Devices, Germany, Category Revenues ($ mn), 2000-2012
- Figure 22: Diabetes Care Devices Market, Germany, Portfolio Analysis
- Figure 23: Diabetes Care Devices, Germany, Category Revenues ($ mn), Historic, 2000-2007
- Figure 24: Diabetes Care Devices, Germany, Category Revenues ($ mn), Forecast, 2007-2012
- Figure 25: Diabetes Care Devices, Germany, Category Volume (Units), 2000-2012
- Figure 26: Diabetes Care Devices, Germany, Category Volume (Units), Historic, 2000-2007
- Figure 27: Diabetes Care Devices, Germany, Category Volume (Units), Forecast, 2007-2012
- Figure 28: Diabetes Care Devices, Germany, Overall Company Share (%), 2007
- Figure 29: Glucose Monitoring, Germany, Revenue ($ mn) by Segment, Historic, 2000-2007
- Figure 30: Glucose Monitoring, Germany, Revenue ($ mn) by Segment, Forecast, 2007-2012
- Figure 31: Glucose Monitoring, Germany, Volume (Units) by Segment, Historic, 2000-2007
- Figure 32: Glucose Monitoring, Germany, Volume (Units) by Segment, Forecast, 2007-2012
- Figure 33: Glucose Monitoring, Germany, Company Share (%), 2007
- Figure 34: Insulin Delivery , Germany, Revenue ($ mn) by Segment, Historic, 2000-2007
- Figure 35: Insulin Delivery , Germany, Revenue ($ mn) by Segment, Forecast, 2007-2012
- Figure 36: Insulin Delivery , Germany, Company Share (%), 2007
- Figure 37: F. Hoffmann-La Roche Ltd., Value Chain Analysis
- Figure 38: Abbott Laboratories, Value Chain Analysis
- Figure 39: Becton, Dickinson and Company, Value Chain Analysis
- Figure 40: B. Braun Melsungen AG, Value Chain Analysis
- Figure 41: Bayer HealthCare AG, Value Chain Analysis
- Figure 42: Global Markets Direct Methodology